# Angiogenesis and VEGF in Cancer

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the molecular mechanisms of angiogenesis, including the role of VEGF, endothelial progenitor cells, pericytes, and anti-angiogenic therapy in regulating tumor vasculature and vascular function. It explores the signaling pathways, therapeutic targets, and clinical applications related to angiogenesis. |
| Domain | Life Sciences |
| Field | Biochemistry, Genetics and Molecular Biology |
| OpenAlex ID | t10422 |
| Works | 398 |

## Topic papers all

Showing 15 of 398.

- [Isolation of Putative Progenitor Endothelial Cells for Angiogenesis](https://scholariq.org/papers/isolation-of-putative-progenitor-endothelial-cells-for-angiogenesis/)
- [Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer](https://scholariq.org/papers/paclitaxel-carboplatin-alone-or-with-bevacizumab-for-non-small-cell-lung-cancer/)
- [Circulating Angiogenic Factors and the Risk of Preeclampsia](https://scholariq.org/papers/circulating-angiogenic-factors-and-the-risk-of-preeclampsia/)
- [Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer](https://scholariq.org/papers/paclitaxel-plus-bevacizumab-versus-paclitaxel-alone-for-metastatic-breast-cancer/)
- [A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma](https://scholariq.org/papers/a-randomized-trial-of-bevacizumab-for-newly-diagnosed-glioblastoma/)
- [A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer](https://scholariq.org/papers/a-randomized-trial-of-bevacizumab-an-anti-vascular-endothelial-growth-factor/)
- [Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer](https://scholariq.org/papers/concurrent-cisplatin-based-radiotherapy-and-chemotherapy-for-locally-advanced/)
- [Antitumor Activity of Thalidomide in Refractory Multiple Myeloma](https://scholariq.org/papers/antitumor-activity-of-thalidomide-in-refractory-multiple-myeloma/)
- [Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer](https://scholariq.org/papers/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-cancer/)
- [Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-monotherapy-for-previously-treated-advanced-gastric-or-gastro/)
- [Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.](https://scholariq.org/papers/effect-of-preoperative-chemotherapy-on-the-outcome-of-women-with-operable-breast/)
- [A Phase 3 Trial of Bevacizumab in Ovarian Cancer](https://scholariq.org/papers/a-phase-3-trial-of-bevacizumab-in-ovarian-cancer/)
- [Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study](https://scholariq.org/papers/prognostic-factors-for-overall-survival-in-patients-with-metastatic-renal-cell/)
- [Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction](https://scholariq.org/papers/intracoronary-bone-marrow-derived-progenitor-cells-in-acute-myocardial/)
- [Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma](https://scholariq.org/papers/tumor-angiogenesis-a-new-significant-and-independent-prognostic-indicator-in/)

## Topic primary papers

Showing 15 of 164.

- [Isolation of Putative Progenitor Endothelial Cells for Angiogenesis](https://scholariq.org/papers/isolation-of-putative-progenitor-endothelial-cells-for-angiogenesis/)
- [Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma](https://scholariq.org/papers/tumor-angiogenesis-a-new-significant-and-independent-prognostic-indicator-in/)
- [Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial](https://scholariq.org/papers/therapeutic-angiogenesis-for-patients-with-limb-ischaemia-by-autologous/)
- [Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals](https://scholariq.org/papers/redefining-endothelial-progenitor-cells-via-clonal-analysis-and-hematopoietic/)
- [Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures](https://scholariq.org/papers/human-endothelial-progenitor-cells-from-type-ii-diabetics-exhibit-impaired/)
- [Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors](https://scholariq.org/papers/flk1-positive-cells-derived-from-embryonic-stem-cells-serve-as-vascular/)
- [Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction](https://scholariq.org/papers/mobilization-of-endothelial-progenitor-cells-in-patients-with-acute-myocardial/)
- [Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.](https://scholariq.org/papers/therapeutic-angiogenesis-a-single-intraarterial-bolus-of-vascular-endothelial/)
- [Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation](https://scholariq.org/papers/angiopoietin-2-sensitizes-endothelial-cells-to-tnf-and-has-a-crucial-role-in-the/)
- [Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization](https://scholariq.org/papers/transplanted-cord-blood-derived-endothelial-precursor-cells-augment-postnatal/)
- [Endothelial Progenitor Cell Dysfunction](https://scholariq.org/papers/endothelial-progenitor-cell-dysfunction/)
- [Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability](https://scholariq.org/papers/selective-requirement-for-src-kinases-during-vegf-induced-angiogenesis-and/)
- [Age-Dependent Impairment of Angiogenesis](https://scholariq.org/papers/age-dependent-impairment-of-angiogenesis/)
- [IDENTIFICATION OF POLYMORPHISMS WITHIN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE: CORRELATION WITH VARIATION IN VEGF PROTEIN PRODUCTION](https://scholariq.org/papers/identification-of-polymorphisms-within-the-vascular-endothelial-growth-factor/)
- [Vascular endothelial growth factor enhances atherosclerotic plaque progression](https://scholariq.org/papers/vascular-endothelial-growth-factor-enhances-atherosclerotic-plaque-progression/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.